Integrated Neuroscience Research Support
Creative Biolabs provides integrated neuroscience research services for neural development studies, CNS disease modeling, neurotoxicity evaluation, mechanism-of-action research, and preclinical drug discovery, with technical consultation, custom experimental models, functional and imaging assays, screening workflows, data analysis, and project-based scientific collaboration.
Service Portfolio
Projects can begin with a single model or assay and expand into a coordinated program. The portfolio links human-relevant neural models, mechanistic readouts, screening capabilities, and research tools so that experimental choices remain aligned with the study question.
Build experimental systems around the biology of interest, from neural lineage generation to three-dimensional and tissue-relevant models. Options include custom brain spheroids and organoids, CNS disease models, blood-brain barrier models, and custom neural differentiation.
Characterize neural identity, viability, morphology, signaling, excitability, and compound response with complementary molecular, imaging, and functional readouts. Assays can be selected individually or combined into a study-specific panel.
Support model construction, perturbation, labeling, and neural circuit studies with project-relevant research tools, including viral vectors, neuronal marker antibodies, neuroactive peptides, neuromodulating compounds, reprogramming factors, optogenetic tools, and cell preparations.
Integrate disease-relevant models with phenotypic, functional, and toxicity endpoints to support compound prioritization and follow-up investigation. Study scope is matched to the biological hypothesis, development stage, and evidence needed for the next decision.
Not sure where to start? Share the research question, model preference, and desired readouts.
Scientific Approach
Neural models differ in cellular composition, maturity, spatial organization, accessibility, throughput, and functional complexity. A useful study design therefore starts with the biological question and selects the simplest model that can capture the required mechanism, followed by orthogonal readouts that test identity, health, phenotype, and function.
Define the neural lineage, cell source, disease context, perturbation, and culture format needed to represent the study question.
Balance physiological context with experimental control, imaging access, sample demand, and the throughput appropriate to the program.
Combine complementary endpoints such as marker expression, morphology, viability, calcium signaling, electrophysiology, or phenotypic imaging where the project requires them.
Use early observations and agreed quality checks to guide assay refinement, follow-up experiments, or progression to a more complex model.
Project Workflow
The final study plan is customized after technical discussion. A typical collaboration follows the sequence below.
Clarify the research objective, comparator strategy, desired endpoints, and decision criteria.
Select the model, assay panel, controls, sampling plan, and analysis approach.
Prepare the agreed model or research tools and confirm project-specific quality attributes.
Run treatments and measurements according to the approved experimental plan.
Organize results, discuss findings in context, and identify rational follow-up options.
Applications
The same service portfolio can be configured for exploratory biology, assay development, or compound-focused studies.
Study lineage specification, maturation, cellular identity, and responses across neural cell types.
Investigate disease-relevant phenotypes in customized cell, spheroid, organoid, or barrier systems.
Evaluate viability, morphology, differentiation, signaling, and functional responses after exposure.
Connect controlled perturbations to molecular, phenotypic, and functional consequences.
Prioritize compounds using imaging, activity, electrophysiology, or other fit-for-purpose endpoints.
Support labeling, manipulation, and measurement strategies for neuronal activity and connectivity questions.
Why Work with Neurost
Bring models, research tools, assays, and data interpretation into one coordinated scientific plan built around the question your program needs to answer.
Align model generation, research tools, assays, and downstream screening within one project plan.
Select cell context, model complexity, perturbations, controls, and endpoints around the actual research need.
Combine molecular, morphological, viability, imaging, and functional measurements when appropriate.
Use agreed checkpoints to refine experiments or plan the next stage of the research program.
Deliverables and Collaboration
The exact package is defined before project execution.
Model, groups, controls, endpoints, and analysis plan.
Project records and relevant quality observations.
Agreed raw data, processed results, figures, or tables.
Interpretive review and follow-up options where requested.
Related Research
Cho and colleagues combined a human brain-derived extracellular matrix with periodic microfluidic flow to improve brain organoid survival, reduce variability, and support cortical organization and electrophysiological maturation. The study reinforces the value of integrating tissue-specific microenvironments, controlled culture conditions, and functional readouts when building human 3D neural models for disease research and drug development.
Cho, Ann-Na, et al. “Microfluidic Device with Brain Extracellular Matrix Promotes Structural and Functional Maturation of Human Brain Organoids.” Nature Communications, vol. 12, 2021, article 4730. https://doi.org/10.1038/s41467-021-24775-5. CC BY 4.0.
Pamies and colleagues described an iPSC-derived brain microphysiological system containing multiple neural cell types and applied it to neurological disease and toxicity questions. The study highlights the value of pairing human cell context with defined characterization and exposure readouts.
Pamies, David, et al. “A Human Brain Microphysiological System Derived from Induced Pluripotent Stem Cells to Study Neurological Diseases and Toxicity.” ALTEX, vol. 34, no. 3, 2017, pp. 362–376. https://doi.org/10.14573/altex.1609122.
Nierode and colleagues used a microarray chip platform to compare toxicity and phenotypic responses in three-dimensional human neural progenitor cultures. The work is directly relevant to designing scalable neural screens in which culture state, assay format, and quantitative endpoints are considered together.
Nierode, Gregory J., et al. “High-Throughput Toxicity and Phenotypic Screening of 3D Human Neural Progenitor Cell Cultures on a Microarray Chip Platform.” Stem Cell Reports, vol. 7, no. 5, 2016, pp. 970–982. https://doi.org/10.1016/j.stemcr.2016.10.001.
Literature examples are provided for scientific context and do not imply identical methods or outcomes.
FAQ
The answers below describe the service-planning process at a general level. Final methods and deliverables are defined for each project.
Tell us about your research objective, preferred model or assay, and desired readouts. Our scientific team will follow up to discuss a project-specific approach.
